Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: Identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping-Reference-Cited by-同舟云学术

Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: Identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping

Published:2002-03-19 Issue:1 Volume:34 Page:42-47
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Sait Sheila N.J.,Qadir Misbah U.,Conroy Jeffrey M.,Matsui Sei-Ichi,Nowak Norma J.,Baer Maria R.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference36 articles.

1. Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas

2. ACUTE MYELOGENOUS LEUKAEMIA WITH C-MYC AMPLIFICATION AND DOUBLE MINUTE CHROMOSOMES

3. Amplification on double-minute chromosomes and partial-tandem duplication of theMILL gene in leukemic cells of a patient with acute myelogenous leukemia

4. Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia

5. Double minutes in human tumor cells

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micronuclei, dmin chromosomes and MYC amplifications as a singular presentation of myeloid malignancies;British Journal of Haematology;2020-07-05

2. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS);Cancer Genetics;2019-10

3. JAK 2 double minutes with resultant simultaneous amplification of JAK 2 and CD 274 in a therapy‐related myelodysplastic syndrome evolving into an acute myeloid leukaemia;British Journal of Haematology;2018-08-21

4. MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences;Leukemia;2018-02-22

5. Mitochondria Remodeling in Cancer;Mitochondrial Biology and Experimental Therapeutics;2018